CCR Clinical Trials at NIH: Clinical Research: Search for Clinical Trials at NIH

The NCI Center for Cancer Research (CCR) conducts more than 150 cancer clinical trials at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. Cancer clinical trials that take place at the NIH Clinical Center are open to patients with cancer, regardless of where they live in the United States.

Go to Search Page

There are 5 clinical trials at NIH that match your search criteria

Cancer by type/disease: Multiple Myeloma

Trial and Protocol Number Graft-Versus-Host Disease	Principal Investigator	Referral Contact
No Phase
Prospective Assessment of Clinical and Biological Factors Determining Outcomes in Patients With Chronic Graft-Versus-Host Disease (GVHD) NCI-04-C-0281	Steven Z. Pavletic 301-402-4899	Caroline Stewart 301-451-6569 cstewartv@mail.nih.gov

Trial and Protocol Number Hematologic/Blood Cancers	Principal Investigator	Referral Contact
Phase II
Allogeneic HSCT Without Preparative Chemotherapy or With Low-Intensity Preparative Chemotherapy Using Sirolimus and Sirolimus Generated Donor Th2 Cells for Therapy of Refractory Leukemia, Lymphoma, Myeloma, or Myelodysplastic Syndrome NCI-04-C-0055	Daniel Fowler 301-435-8641	Zetta Blacklock 301-594-2056 bblacklock@mail.nih.gov
Phase I/II
Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation Using 8/8 and 7/8 HLA-Matched Unrelated Donors and Utilizing Two Graft-versus-Host Disease Prophylaxis Regimens for the Treatment of Leukemias, Lymphomas, and Pre-malignant Blood Disorders NCI-07-C-0195	Michael R. Bishop 301-435-2764	Zetta Blacklock 301-594-2056 bblacklock@mail.nih.gov
Phase I
Adoptive Cell Therapy for B-Cell Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation With Costimulated, Tumor-Derived Lymphocytes NCI-07-C-0064	Michael R. Bishop 301-435-2764	Zetta Blacklock 301-594-2056 bblacklock@mail.nih.gov
T-Cell Depleted, Reduced-Intensity Allogeneic Stem Cell Transplantation From Haploidentical Related Donors for Hematologic Malignancies NCI-04-C-0116	Michael R. Bishop 301-435-2764	Zetta Blacklock 301-594-2056 bblacklock@mail.nih.gov

For additional studies that may be appropriate for your disease type, please search under Solid Tumor.